[7] Zhang J,Liu RJ, et al. 9MW2821, a nectin-4 antibody-drug conjugate (ADC), in patientswith advanced solid tumor: Results from a phase 1/2a study. 2024 ASCO Abstract3013,[8] Ye DW,Zhang jian, et al. Clinical update related to the first-in-human trial ofSYS6002 (CRB-701), ...
Nectin-4/PVRL4 primary antibody included. 推荐稀释比 ApplicationDilution Western Blot (WB) WB : 1:500-1:3000 It is recommended that this reagent should be titrated in each testing system to obtain optimal results. Sample-dependent, Check data in validation data gallery. 产品信息 67721-1-Ig ...
Challita-Eid PM, Satpayev D, Yang P, et al. Enfortumab vedotin antibody-drug conjugate targeting nectin-4 is a highly potent therapeutic agent in multiple preclinical cancer models. Cancer Res. 2016;76(10):3003-13. 聚焦生物创新...
关键字:NECTIN4;NECTIN4抗体;NECTIN4 antibody ; 公司简介 湖北艾普蒂生物工程有限公司(简称:艾普蒂)由在国内科研试剂领域有着十几年从业经验的专业技术团队和企业管理团队组建而成,专门从事以抗体、蛋白、细胞、化学品为核心的试剂产品研发与销售。 我们长期聚焦于生命科学、生物医药、医疗诊断、分析检测等领域,专注于...
[1]中国国家药监局药品审评中心(CDE)官网.Retrieved Mar 27,2025, From https://www.cde.org.cn/main/xxgk/listpage/4b5255eb0a84820cef4ca3e8b6bbe20c [2]NEXUS-01, a phase 1 study of LY4052031, an antibody-drug conjugate targeting Nectin-4...
Antibody 克隆号 NECT4/7271 抗原 Recombinant fragment (around aa1-200) of human NECTIN4 protein. 查看免疫原 偶联物 Unconjugated 形式 Liquid 浓度 200 µg/mL 纯化类型 Protein A/G 保存液 PBS, pH 7.4, with 0.05% BSA 内含物 0.05% sodium azide ...
[1]Progress in the study of antibody-drug conjugates for the treatment of cervical cancer. Front Oncol. 2024 Jun 6;14:1395784. doi: 10.3389/fonc.2024.1395784. PMID: 38903711; PMCID: PMC11187480. [2]Expression of nectin-4 in prostate cancer. North Clin Istanb. 2023 Sep 25;10(5):583-588...
1 antibody GeneTex 1 antibody OriGene 1 antibody Creative Biolabs 24 antibodies Aviva Systems Biology 2 antibodies St John's Laboratory 2 antibodies Abnova Corporation 4 antibodies NSJ Bioreagents 2 antibodies Abgent 1 antibody Miltenyi Biotec
[6] Deng, H., Shi, H., Chen, L. et al. Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients. Cancer Cell Int 19, 106 (2019). [7] Zhang J, Liu RJ, et al. 9MW2821, a nectin-4 antibody-drug conjugate (ADC), ...
[6] Deng, H., Shi, H., Chen, L. et al. Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients. Cancer Cell Int 19, 106 (2019). [7] Zhang J, Liu RJ, et al. 9MW2821, a nectin-4 antibody-drug conjugate (ADC), ...